Clinical Trial Update: Randomized，Controlled and Open-label Study of Buspirone add-on Treatment in Patients With Major Depression Disorder [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 randomized, controlled and open-label trial evaluating buspirone as add-on therapy for major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Buspirone (buspirone)

Snippet

Sponsor: Si Tianmei | Conditions: Major Depression Disorder | Phase 4 | Status: UNKNOWN